ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update

Medicine and Dentistry

• Prostate Cancer 100%
• Disease 33%
• Magnetic Resonance Imaging 33%
• Biopsy 33%
• Recurrent Disease 16%
• Positron Emission Tomography-Computed Tomography 16%
• Cancer 16%
• Bone Scintigraphy 16%
• Membrane Antigen 16%
• Prostate Specific Antigen 16%
• Lung Cancer 16%
• Transrectal Ultrasonography 16%
• Digital Rectal Examination 16%
• Whole Body MRI 16%
• Nodal Metastasis 16%

Keyphrases

• ACR Appropriateness Criteria 100%
• Intravenous Contrast 20%
• RAND Appropriateness Method 20%
• Treatment Verification 20%
• Membrane Antigens 20%
• Bone Scintigraphy 20%
• Guideline Revision 20%